50 new jobs possible as ResMed announces expansion at UCD

ResMed, a global leader in the development, manufacturing and marketing of medical products to combat sleep and respiratory disorders, is expanding its Research Development and Innovation (RD&I) facility in Dublin over the next three years, with the creation of up to 50 new RD&I positions.

The investment, supported by the Irish Government through IDA Ireland will allow ResMed to extend its existing operation in NexusUCD, the Innovation Partnerships Centre at University College Dublin.

The new jobs created will facilitate the development of a technology platform based on non-contact sensors designed to manage patients with chronic diseases in their home and will be carried through all stages; product standardisation, development of software algorithms, clinical trials and engineering for commercialisation. It will therefore rank among the most comprehensive medical device development projects ever undertaken by a multinational company in Ireland.

ResMed founder, Chairman and Chief Executive Officer Dr Peter Farrell said, “We believe there are great opportunities in growing our presence in Ireland. One of the factors that played a part in our 2011 acquisition of BiancaMed, a UCD spin-out company, was the tremendous advantage of being based in a country that strongly supports research and development.”

Barry O’Leary, Chief Executive of IDA Ireland said: “I am delighted that ResMed has joined Ireland’s strong growing cluster of leading Global and Indigenous Medical Device Companies. This expansion by ResMed Inc is a further endorsement of Ireland’s long established reputation in supporting Research, Development and Innovation. Expansions such as this are critical as they embed existing operations and facilitate future investment and job creation. I wish ResMed every success with its continued growth in Ireland and offer the ongoing support of IDA Ireland”.